Gene Research Foundation, part of Dr Agarwal Hospitals and Manacells, has set a new benchmark in the field of healthcare by developing a product called Mana (DNA activator) wherein a patient is treated for disorders by replacing the defective gene with a new one. Many of these genes play a role in diverse clinical situations—from severe intellectual disability to adult-onset schizophrenia.
View the original article here: Gene Research Foundation develops DNA activator – Express Healthcare